Clinical Trials Directory

Trials / Completed

CompletedNCT06260930

Value of Chest Ultrasonography in ILD Screening

Role od Chest Ultrasonography in Interstitial Lung Diseases

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Aswan University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

The main aim of this study is to detect the value of transthoracic ultrasonography in the diagnosis and assessment of ILDs in correlation to chest X- ray, blood gases, pulmonary function test and echocardiography and to compare it with high resolution CT (HRCT) as a golden diagnostic investigation.

Detailed description

Interstitial lung disease (ILD) refers to a group of disorders that are characterized by varying combinations of inflammation and fibrosis involving the space between the epithelial and endothelial basement membranes.

Conditions

Timeline

Start date
2017-01-01
Primary completion
2019-09-01
Completion
2019-12-01
First posted
2024-02-15
Last updated
2024-02-15

Source: ClinicalTrials.gov record NCT06260930. Inclusion in this directory is not an endorsement.